IDO1 and melanoma: In the field of post-transcriptional control therapy, a vaccine of siRNA and Trp2 coated with PEI nanoparticles and indoleamine 2,3-dioxygenase (IDO) delivered by recombinant S. cerevisiae inhibited IDO expression and induced T-cell responses against melanoma in mice [138].